Detalles de la búsqueda
1.
Development and implementation of a comprehensive psychosocial screening program in a Brazilian cancer center.
Psychooncology
; 25(11): 1343-1349, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27568489
2.
Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committe.
Hematol Transfus Cell Ther
; 42(3): 200-205, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32405620
3.
How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation.
Hematol Transfus Cell Ther
; 42(2): 103-110, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32313873
4.
Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation.
Hematol Transfus Cell Ther
; 42(2): 118-124, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31537476
5.
The Brazilian association of hematology, hemotherapy, and cell therapy (ABHH) and its absolute commitment to ethics and absence of conflicts of interest.
Hematol Transfus Cell Ther
; 46(3): 219-220, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38821779
6.
BCL-2 as therapeutic target for hematological malignancies.
J Hematol Oncol
; 11(1): 65, 2018 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29747654
7.
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I.
Hematol Transfus Cell Ther
; 44(3): 410-418, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35970751
8.
Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committe
Hematol., Transfus. Cell Ther. (Impr.)
; 42(3): 200-205, July-Sept. 2020.
Artículo
en Inglés
| LILACS | ID: biblio-1134043
9.
Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
Hematol., Transfus. Cell Ther. (Impr.)
; 42(2): 118-124, Apr.-June 2020. tab, ilus
Artículo
en Inglés
| LILACS | ID: biblio-1134012
10.
Unmet needs in multiple myeloma in Brazil from physicians' perspective barriers in quality of life and disease management / Necessidades não atendidas em mieloma múltiplo no Brasil sob a perspectiva de médicos barreiras na qualidade de vida e manejo da doença
J. bras. econ. saúde (Impr.)
; 10(2): 165-171, Agosto/2018.
Artículo
en Inglés
| LILACS, ECOS | ID: biblio-915106
11.
Guidelines on the diagnosis and management of multiple myeloma treatment: Associac ao Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I
Hematol., Transfus. Cell Ther. (Impr.)
; 44(3): 410-418, July-Sept. 2022.
Artículo
en Inglés
| LILACS | ID: biblio-1405010
Resultados
1 -
11
de 11
1
Próxima >
>>